Dynamic ACL Brace: In Vivo Kinematics

Sponsor
Steadman Philippon Research Institute (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03670550
Collaborator
Össur Ehf (Industry)
0
1
1
14
0

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effect of the Össur Rebound dynamic ACL brace on knee kinematics evaluated using dynamic stereo X-ray (DSX) imaging during functional activities. Brace performance will be evaluated before and after ACL reconstruction.

Condition or Disease Intervention/Treatment Phase
  • Device: Ossur Rebound ACL Brace
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Evaluation of knee stability with brace wear. Control is same subject without the brace.Evaluation of knee stability with brace wear. Control is same subject without the brace.
Masking:
None (Open Label)
Masking Description:
Investigators and participants cannot be blinded as to whether or not the brace is worn.
Primary Purpose:
Basic Science
Official Title:
Dynamic ACL Brace: In Vivo Kinematics
Anticipated Study Start Date :
Oct 1, 2018
Anticipated Primary Completion Date :
Apr 1, 2019
Anticipated Study Completion Date :
Dec 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Knee Brace

ACL-reconstruction patients will be issued an Ossur Rebound ACL Brace at the time of enrollment in the study, prior to surgery. They will use this brace throughout their rehab and physical therapy. Dynamic X-ray imaging of the knee will take place prior to surgery, and again upon clearance from physical therapy 7-9 months after surgery. The injured knee will be imaged with and without the brace, and the contralateral limb will be imaged for use as a control.

Device: Ossur Rebound ACL Brace
ACL-reconstruction patients will be issued an Ossur Rebound ACL Brace at the time of enrollment in the study, prior to surgery. They will use this brace throughout their rehab and physical therapy. The intervention (brace) will be applied only to the surgical limb.

Outcome Measures

Primary Outcome Measures

  1. Dynamic tibiofemoral kinematics during activities of daily living in ACL-deficient knees [<1wk (pre-operative)]

    This study will use dynamic stereo x-ray (pulsed bi-plane fluoroscopy) to measure the dynamic movements of the tibiofemoral joint during walking and stair-climbing, focusing on differences in anterior-posterior sliding and internal/external rotation of the tibia relative to femur, between the braced ACL-deficient knee, unbraced ACL-deficient knee, and the contralateral/uninjured knee.

  2. Dynamic tibiofemoral kinematics during sports activities in ACL-reconstructed-knees [7-9 months (post-operative)]

    This study will use dynamic stereo x-ray (pulsed bi-plane fluoroscopy) to measure the dynamic movements of the tibiofemoral joint during dynamic movements and sports activities, focusing on differences in anterior-posterior sliding and internal/external rotation of the tibia relative to femur, between the braced ACL-reconstructed knee, unbraced ACL-reconstructed knee, and contralateral/uninjured knee.

Secondary Outcome Measures

  1. Percent symmetry in 3D motion capture kinematics and kinetics [<1wk; 7-9months]

    Whole-body kinematics and ground reaction forces will be calculated to assess joint angle and ground reaction force symmetry between braced and unbraced conditions during activities of daily living (<1wk) and dynamic/sports activities(7-9months post-operatively).

  2. Muscle contribution levels in braced vs unbraced knee [<1wk; 7-9 months]

    Electromyography sensors will detect differences in muscle contributions (in major muscles of the lower extremity) between the braced ipsilateral leg, unbraced ipsilateral leg, and contralateral leg during activities of daily living and dynamic sports activities.

  3. Subject Satisfaction [2 months; 4 months; 7-9 months]

    An overall satisfaction score for brace comfort will be obtained from the 'Quebec User Evaluation of Satisfaction with Assistive Technology.'

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Unilateral, complete ACL (Anterior Cruciate Ligament) ruptures (must be documented by prior MRI)

  • No other concomitant lower extremity injuries and an uninjured contralateral limb

  • Acute ACL tears that will be scheduled for ACL reconstruction with Dr. Robert F. LaPrade

  • Minimal swelling and pain

  • Able and willing to perform the required study activities

Exclusion Criteria:
  • Previous surgery or significant injury to either knee

  • Relevant surgery, procedure, injury, or condition in the past two years which may affect knee pain or general movement patterns on either side

  • Diagnosis of osteoarthritis, rheumatoid conditions, cancers, or other conditions which may affect musculoskeletal health

  • Women who are pregnant, or trying/planning to become pregnant during the next 10 months

  • Known balance or vestibular disorders

  • Persons with a history of significant radiation exposure, whether occupational or medical in nature (Anyone with a history of medical radiation therapy, for cancer or other conditions, is excluded from the study. Those who have an annual occupational radiation exposure greater than 25mSv may not enroll.)

  • Persons with a pacemaker, hearing aid, aneurysm clip or artificial heart valve, or other forms of loose metal implants

  • Initial MRI exclusion criteria (assessed by clinical MRI obtained as standard of care at time of ACL injury diagnosis): concomitant injury, multi-ligamentous injury, significant meniscal damage

  • Allergy or sensitivity to silver or latex

  • Adults lacking capacity to consent for themselves

Post-Op Visit Exclusion Criteria

  • Participants who do not pass their return-to-sport test within 7-9 months of ACL-Reconstruction surgery will be excluded from the second phase of testing.

  • Participants who no longer pass the MRI screening at the time of Phase 2 testing (for example, who have a new loose metal implant), will be excluded from the MRI portion of the testing only.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Steadman Philippon Research Institute Vail Colorado United States 81657

Sponsors and Collaborators

  • Steadman Philippon Research Institute
  • Össur Ehf

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Steadman Philippon Research Institute
ClinicalTrials.gov Identifier:
NCT03670550
Other Study ID Numbers:
  • 2018-31
First Posted:
Sep 13, 2018
Last Update Posted:
Feb 15, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2019